ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

In Brief: French 10 Years Behind In Treatment Techniques, Rauscher Tells Premier; European Interest Grows

September 26, 1975

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

Obituary: Hayden Braine, 67, Blood Cell Transfusion Pioneer At Hopkins

November 19, 2010